The American Journal of Surgery, Год журнала: 2022, Номер 224(4), С. 1109 - 1114
Опубликована: Июнь 21, 2022
Язык: Английский
BJOG An International Journal of Obstetrics & Gynaecology, Год журнала: 2022, Номер 130(4), С. 348 - 357
Опубликована: Ноя. 29, 2022
There are limited data regarding COVID-19 vaccination during pregnancy.To evaluate the effects of received pregnancy on SARS-CoV-2 infection, COVID-19-related hospitalisation, intensive care unit (ICU) admission and maternal-fetal complications.MEDLINE, CINHAL, Embase, Scopus CENTRAL databases, as well ClinicalTrials.gov, reference lists, related articles grey literature sources.Randomised controlled trials, non-randomised studies interventions, pregnant women, pregnancy.Study selection, risk-of-bias assessment, extraction assessment certainty evidence using GRADE method were performed independently by two authors. Meta-analyses Cochrane RevMan 5.4. PROSPERO registration number: CRD42022308849.We included 14 observational (362 353 women). The administration a vaccine resulted in statistically significant reduction infection (OR 0.46, 95% CI 0.28-0.76) hospitalisation 0.41, 0.33-0.51). effect appeared to be greater fully vaccinated for both 0.31, 0.16-0.59) 0.15, 0.10-0.21). However, was very low. difference ICU between unvaccinated individuals did not reach statistical significance 0.58, 0.13-2.58). Finally, there no differences any complications considered studies.COVID-19 administered seems reduce with complications.
Язык: Английский
Процитировано
25
Obstetrics & Gynecology Science, Год журнала: 2023, Номер 66(4), С. 270 - 289
Опубликована: Май 17, 2023
The coronavirus disease 2019 (COVID-19) outbreak which started in December rapidly developed into a global health concern. Pregnant women are susceptible to respiratory infections and can experience adverse outcomes. This systematic review meta-analysis compared pregnancy outcomes according COVID-19 status. MEDLINE, EMBASE, Cochrane Library databases were searched for relevant articles published between 1, 2019, October 19, 2022. Main inclusion criterion was any population-based, cross-sectional, cohort, or case-control study that assessed with without laboratory-confirmed COVID-19. Sixty-nine studies including 1,606,543 pregnant (39,716 [2.4%] diagnosed COVID-19) retrieved. COVID-19-infected had higher risk of preterm birth (odds ratio [OR], 1.59; 95% confidence interval [CI], 1.42-1.78), preeclampsia (OR, 1.41; CI, 1.30-1.53), low weight 1.52; 1.30-1.79), cesarean delivery 1.20; 1.10-1.30), stillbirth 1.71; 1.39-2.10), fetal distress 2.49; 1.54-4.03), neonatal intensive care unit admission 2.33; 1.72-3.16), perinatal mortality 1.96; 1.15-3.34), maternal 6.15; 3.74-10.10). There no significant differences total miscarriage, premature rupture membranes, postpartum hemorrhage, cholestasis, chorioamnionitis infection. demonstrates infection during lead information could aid researchers clinicians preparing another pandemic caused by newly discovered viruses. findings this may assist evidence-based counseling help manage
Язык: Английский
Процитировано
15
npj Vaccines, Год журнала: 2024, Номер 9(1)
Опубликована: Авг. 14, 2024
Abstract Vaccines against COVID-19 and influenza can reduce the adverse outcomes caused by infections during pregnancy, but vaccine uptake among pregnant women has been suboptimal. We examined disparities in pandemic to inform vaccination interventions. used data from Oxford-Royal College of General Practitioners Research Surveillance Centre database England Secure Anonymised Information Linkage Databank Wales. The at least one dose was 40.2% for 41.8% eligible women. observed uptake, with socioeconomically deprived ethnic minority groups showing lower rates. suboptimal vaccines, especially those backgrounds Black, mixed or other groups, underscores necessity interventions hesitancy enhance acceptance
Язык: Английский
Процитировано
5
The Lancet Respiratory Medicine, Год журнала: 2023, Номер 11(6), С. 520 - 529
Опубликована: Фев. 3, 2023
Язык: Английский
Процитировано
10
Biomedicines, Год журнала: 2025, Номер 13(2), С. 282 - 282
Опубликована: Янв. 24, 2025
Introduction: The emergence of the SARS-CoV-2 virus and its subsequent global pandemic have raised significant concerns regarding impact on pregnancy outcomes. This review aims to summarize emerging data risk preterm delivery in pregnant women infected with SARS-CoV-2. Materials Methods: A systematic search was conducted from March 2020 December 2023 using PubMed Web Science, following PRISMA guidelines. Studies correlating maternal COVID-19 infection birth were included. Results: Thirteen studies analyzed, indicating a higher incidence SARS-CoV-2-positive compared controls. average rate patients 18.5%, median 12.75%, while non-infected showed an 10%, 8.2%. Discussion: suggest association between during increased cesarean section. severity symptoms underlying comorbidities further elevate this risk. Notably, infections third trimester pose highest birth. Conclusion: Preventing is crucial mitigate adverse obstetric Close monitoring tailored interventions for women, particularly those later trimesters comorbidities, are imperative reduce improve maternal-fetal
Язык: Английский
Процитировано
0
PEDIATRICS, Год журнала: 2025, Номер unknown
Опубликована: Март 14, 2025
BACKGROUND AND OBJECTIVES COVID-19 vaccination is recommended during pregnancy; however, evidence on the prevalence of major structural birth defects born to people vaccinated early in pregnancy (≤20 weeks gestation) limited. We compared by status and key strata: insurance provider, clinically diagnosed SARS-CoV-2 infection pregnancy, concomitant administration other maternal vaccines. also compared, head-to-head, brand (Moderna mRNA-1273 vs Pfizer-BioNTech BNT162b2). METHODS A claims-based cohort study captured pregnancies ending a live among with an estimated last menstrual period between August 15, 2021, December 24, 2021. Prevalence ratios comparing exposure vaccines were using binomial regression inverse probability treatment weights. RESULTS Among 78 052 pregnancies, we identified 1248 (1049 [160.6 per 10 000 births] unvaccinated 199 [156.4 people). No differences observed given (adjusted ratio [aPR], 0.96; 95% CI, 0.81–1.13). Findings unchanged (aPR, 1.02; 0.77–1.37). CONCLUSIONS not associated increased infants. These results support safety pregnancy.
Язык: Английский
Процитировано
0
The Journal of Dermatology, Год журнала: 2025, Номер unknown
Опубликована: Апрель 12, 2025
Atopic dermatitis (AD) is a common chronic inflammatory skin condition. COVID-19, novel coronavirus, sparked global pandemic in late 2019. The connection between AD and COVID-19 infection remains unclear; moreover, the risk factors for among patients have not been thoroughly explored. TriNetX Research Network was used to investigate association infection. A logistic regression estimate odds ratio (OR) We found that had significantly higher of compared individuals without AD, regardless age sex. For patients, we younger group (age ≤ 20 years) lower when with old-age groups, while no significant difference females males observed. Hypertension, diabetes mellitus, asthma, ischemic heart disease, overweight obesity increased infection, respectively. treated by dupilumab resulted those methylprednisolone, prednisone, or prednisolone. In conclusion, across all groups sexes. Younger demonstrated risks. Certain comorbidities further patients. Treatment associated
Язык: Английский
Процитировано
0
BMC Infectious Diseases, Год журнала: 2025, Номер 25(1)
Опубликована: Май 9, 2025
Язык: Английский
Процитировано
0
Placenta, Год журнала: 2025, Номер unknown
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0
Annals of Medicine, Год журнала: 2023, Номер 55(2)
Опубликована: Сен. 27, 2023
Although vaccination with the Coronavirus disease 2019 vaccine is important and effective in prevention of SARS-CoV-2 infection, public expressed concerns regarding adverse effects on fertility. Some reviews have focused it, they been unable to collect sufficient research data because earlier publication period. As relevant evidence has gradually increased, we reviewed these studies from perspectives males, females or without pregnancy, different types. The results suggest that although males may experience fluctuations semen parameters within their physiological ranges after receiving vaccine, it not yet reached a level influence partner's pregnancy probability. female believed will affect fertility; however, more needed explore short-term impact. Vaccination during any trimester considered safe pregnant women.
Язык: Английский
Процитировано
9